• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Small miracles: point-of-care testing.

作者信息

Wick Jeannette Y

机构信息

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Consult Pharm. 2010 Jul;25(7):416-8, 425-31. doi: 10.4140/TCP.n.2010.416.

DOI:10.4140/TCP.n.2010.416
PMID:20601347
Abstract

Point-of-care testing (POCT), also called "near patient," "bedside," or "extra-laboratory testing," means any laboratory test performed in patient-care areas or patients' homes, usually by clinical staff who are not trained in clinical laboratory sciences, or by patients themselves. POCT devices may be as different as a hand-held, single-use device or a bench-top analyzer. The growth of POCT has had considerable impact on health care, but cannot replace clinical judgment. The Food and Drug Administration reviews and approves most POCT devices, and the Centers for Medicare & Medicaid Services makes coverage determinations on their usage. POCT is best used when a clinician is prepared to act on test results immediately.

摘要

相似文献

1
Small miracles: point-of-care testing.
Consult Pharm. 2010 Jul;25(7):416-8, 425-31. doi: 10.4140/TCP.n.2010.416.
2
Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.澳大利亚政府全科医疗即时检验试验中设备操作员培训项目的评估:农村及偏远医疗实践的问题与影响
Rural Remote Health. 2009 Jul-Sep;9(3):1189. Epub 2009 Aug 10.
3
The blind hog and the acorn: Medicare coverage for investigational devices.瞎猪和橡子:医疗保险对研究性器械的覆盖范围
J Healthc Resour Manag. 1995 Mar;13(3):31-2.
4
Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.满足美国食品药品监督管理局以及医疗保险和医疗补助服务中心的要求。
J Am Coll Radiol. 2008 Mar;5(3):189-92. doi: 10.1016/j.jacr.2007.09.005.
5
[The current method of handling of test samples and medical reimbursement for POCT in Japan].[日本即时检验(POCT)的检测样本处理及医疗报销现行方法]
Rinsho Byori. 2002 Oct;50(10):958-64.
6
Point of care testing.即时检验
Clin Lab Med. 2007 Dec;27(4):893-908, viii. doi: 10.1016/j.cll.2007.07.003.
7
Miracles in the making.正在创造的奇迹。
Provider. 2003 Mar;29(3):22-6, 28, 31-6.
8
Potential legal barriers to increasing CMS/FDA collaboration: the law of trade secrets and related considerations.加强医疗保险和医疗补助服务中心(CMS)与美国食品药品监督管理局(FDA)合作的潜在法律障碍:商业秘密法及相关考量因素
Food Drug Law J. 2003;58(4):613-27.
9
Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?采用植入式心脏复律除颤器的MADIT II标准——美国食品药品监督管理局批准的作用是什么?
Card Electrophysiol Rev. 2003 Dec;7(4):443-6. doi: 10.1023/B:CEPR.0000023166.65777.6f.
10
Regulatory compliance for point-of-care testing: 2009 United States perspective.即时检验的法规遵循:2009年美国视角
Clin Lab Med. 2009 Sep;29(3):463-78. doi: 10.1016/j.cll.2009.06.012.